Tamayo, Concordia A.

HRN: 12-41-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/03/2026
07/10/2026
IVTT
500 Mg
Q8
Infectious Diarrhea
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines